Andera Life Sciences closes sixth fund above target on EUR 456m
Andera Partners' life sciences arm has closed its sixth life science venture capital fund, BioDiscovery 6, on EUR 456m as LPs increasingly shift capital towards more focused strategies.
More on Venture
World Fund on track for debut climate tech fund final close in 2023
Vehicle has received a “big-ticket investment” from an undisclosed European institutional LP; targets EUR 350m
VC Profile: Future Planet Capital steps up energy security investments alongside new fundraise, acquisitions
Impact investor remains focused on climate change but sees life sciences opportunities amid economic downturn
Newion eyes EUR 140m for new B2B software fund
Dutch investor also has in the pipeline two vehicles to support portfolio companies
EQT closes Europe’s largest VC fund with EUR 1.1bn raised
Registered in September, EQT Ventures III is almost double the size of its predecessor
Latest News
Gresham House reaps 6.9x money on Equip exit
Sale of parent company of specialist outdoor brands Rab and Lowe Alpine is the firm’s third exit this year
GP Profile: EV Private Equity outlines plans for dedicated energy transition fund
Energy sector investor prepares to raise EUR 350m for Article 9 fund targeting renewable, clean tech businesses
KKR invests in CVC's French insurer April Group
US sponsor to become new majority owner; company achieved its objectives more than a year in advance
EQT Infrastructure in exclusivity to buy Trescal
OMERS Private Equity to retain 25% stake in the French calibration laboratories provider